Statins to prevent scar tissue in the eye?

According to a Finnish study, statin medication seems to reduce the risk of repeated surgery in patients who undergo a vitrectomy to treat a detached retina. The researchers believe that statins might prevent the formation of scar tissue inside the eye.

Conducted at the Helsinki University Hospital, the population-based cohort study is based on an extensive store of register data of Finnish who have undergone vitreoretinal eye surgery. The study examined renewed surgeries among 5,709 eye patients who were admitted to hospital for a vitreoretinal surgical procedure between 2008-2014. The novel results indicate that use of at the time of surgery was associated with a 28% reduction in the risk of renewed surgery among patients who underwent a primary vitrectomy to treat .

However, statin medication was not found to be associated with a reduced risk of renewed surgery in the other vitreoretinal disease groups involving retinal surgery, such as age-related macular pucker formation, or vitrectomies performed to treat diabetic retinopathy.

"It seems that is beneficial in the treatment of retinal detachment, the most serious common retinal disorder which may at worst lead to blindness," says Docent Sirpa Loukovaara from the HUCH eye clinic, who led the study. "This means that systemic statin medication may be beneficial not only in the prevention of cardio-vascular diseases, but also in terms of eye health."

The researchers believe that the benefits of statin medication on retinal detachment patients is probably due to the effect of the statin medication on reducing the inflammation inside the eye and hindering the formation of .

"Our previous work has indicated that the amount of biochemical markers related to the scar tissue formation is lower in the vitreous gel of subjects receiving statin medication than it is in the vitreous gel of control subjects without statin, and therefore, we considered it necessary to investigate further our findings," states Loukovaara.

While the results are significant for ophthalmology, they will not directly change the treatment practices of patients who have undergone for retinal detachment. They do, however, invite further study.

"At the moment there is no safe drug treatment that could prevent the formation of scar tissue inside the eye, so we should study the potential benefits of statins in this area. It's possible that in the future, retinal detachment patients thought to benefit from the treatment would receive statin medication as an implant or as an injection inside the eye," says Loukovaara.


Explore further

HDL and kidney injury after surgery

More information: Sirpa Loukovaara et al. Statin use and vitreoretinal surgery: Findings from a Finnish population-based cohort study, Acta Ophthalmologica (2018). DOI: 10.1111/aos.13641

Raimo Tuuminen et al. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment, Acta Ophthalmologica (2014). DOI: 10.1111/aos.12363

Raimo Tuuminen et al. Statins in rhegmatogenous retinal detachment are associated with low intravitreal angiopoietin-2, VEGF and MMP-2 levels, and improved visual acuity gain in vitrectomized patients, Graefe's Archive for Clinical and Experimental Ophthalmology (2014). DOI: 10.1007/s00417-014-2873-2

Citation: Statins to prevent scar tissue in the eye? (2018, January 18) retrieved 21 October 2019 from https://medicalxpress.com/news/2018-01-statins-scar-tissue-eye.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more